{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:02:55Z","timestamp":1787313775994,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,5,27]],"date-time":"2012-05-27T00:00:00Z","timestamp":1338076800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s11239-012-0747-1","type":"journal-article","created":{"date-parts":[[2012,5,26]],"date-time":"2012-05-26T01:23:05Z","timestamp":1337995385000},"page":"545-547","source":"Crossref","is-referenced-by-count":54,"title":["Dabigatran and left atrial appendage thrombus"],"prefix":"10.1007","volume":"34","author":[{"given":"Alejandro","family":"Vidal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Vanerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,5,27]]},"reference":[{"key":"747_CR1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000334979","volume":"33","author":"V Prasad","year":"2012","unstructured":"Prasad V, Kaplan RM, Passman RS (2012) New frontiers for stroke prevention in atrial fibrillation. Cerebrovasc Dis. 33:199\u2013208","journal-title":"Cerebrovasc Dis."},{"key":"747_CR2","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s13311-011-0048-y","volume":"8","author":"WD Freeman","year":"2011","unstructured":"Freeman WD, Aguilar MI (2011) Prevention of cardioembolic stroke. Neurotherapeutics 8:488\u2013502","journal-title":"Neurotherapeutics"},{"key":"747_CR3","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2174\/157016111795495512","volume":"9","author":"O Wolfram","year":"2011","unstructured":"Wolfram O, Hammwoehner M, Gramley F, Goette A (2011) Update on pharmacologic approaches to prevent thromboembolism in atrial fibrillation: are thrombin and factor Xa inhibitors the ultimate answer? Curr Vasc Pharmacol 9:350\u2013357","journal-title":"Curr Vasc Pharmacol"},{"key":"747_CR4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11886-010-0148-z","volume":"13","author":"M Broukhim","year":"2011","unstructured":"Broukhim M, Halperin JL (2011) Stroke prevention in the high-risk atrial fibrillation patient: Medical management. Curr Cardiol Rep. 13:9\u201317","journal-title":"Curr Cardiol Rep."},{"key":"747_CR5","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1161\/STROKEAHA.110.589218","volume":"41","author":"C Medi","year":"2010","unstructured":"Medi C, Hankey GJ, Freedman SB (2010) Stroke risk and antithrombotic strategies in atrial fibrillation. Stroke 41:2705\u20132713","journal-title":"Stroke"},{"key":"747_CR6","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s11936-010-0075-8","volume":"12","author":"CG Santos-Gallego","year":"2010","unstructured":"Santos-Gallego CG, Bay\u00f3n J, Badim\u00f3n JJ (2010) Thrombi of different pathologies: implications for diagnosis and treatment. Curr Treat Options Cardiovasc Med. 12:274\u2013291","journal-title":"Curr Treat Options Cardiovasc Med."},{"key":"747_CR7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/07853890701320662","volume":"39","author":"I Savelieva","year":"2007","unstructured":"Savelieva I, Bajpai A, Camm AJ (2007) Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices. Ann Med 39:371\u2013391","journal-title":"Ann Med"},{"key":"747_CR8","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.amjcard.2005.05.051","volume":"96","author":"SK Thambidorai","year":"2005","unstructured":"Thambidorai SK, Murray RD, Parakh K, Shah TK, Black IW, Jasper SE, Li J, Apperson-Hansen C, Asher CR, Grimm RA (2005) ACUTE investigators. utility of transesophageal echocardiography in identification of thrombogenic milieu in patients with atrial fibrillation (an ACUTE ancillary study). Am J Cardiol 96:935\u2013941","journal-title":"Am J Cardiol"},{"key":"747_CR9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/j.1875-9114.2012.01023.x","volume":"32","author":"LE Odum","year":"2012","unstructured":"Odum LE, Cochran KA, Aistrope DS, Snella KA (2012) The CHADS(2) versus the new CHA(2) DS(2) -VASc scoring systems for guiding Antithrombotic treatment of patients with Atrial Fibrillation: Review of the Literature and Recommendations for Use. Pharmacotherapy 32:285\u2013296","journal-title":"Pharmacotherapy"},{"key":"747_CR10","first-page":"363","volume":"31","author":"J Harenberg","year":"1989","unstructured":"Harenberg J, Leber G, Dempfle CE, Heene DL, Zimmermann R, K\u00fcbler W (1989) Long term anticoagulation with low molecular weight heparin in outpatients with side effects on oral anticoagulants. Nouv Rev Fr Hematol 31:363\u2013369","journal-title":"Nouv Rev Fr Hematol"},{"key":"747_CR11","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1053\/euhj.1999.1869","volume":"21","author":"A Roijer","year":"2000","unstructured":"Roijer A, Eskilsson J, Olsson B (2000) Transoesophageal echocardiography-guided cardioversion of atrial fibrillation or flutter. Selection of a low-risk group for immediate cardioversion. Eur Heart J 21:837\u2013847","journal-title":"Eur Heart J"},{"issue":"684","key":"747_CR12","first-page":"e1","volume":"152","author":"PR Sinnaeve","year":"2006","unstructured":"Sinnaeve PR, Huang Y, Bogaerts K, Vahanian A, Adgey J, Armstrong PW, Wallentin L, Van de Werf FJ (2006) age, outcomes, and treatment effects of fibrinolytic and antithrombotic combinations: findings from assessment of the Safety and Efficacy of a new Thrombolytic (ASSENT)-3 and ASSENT-3 PLUS. Am Heart J 152(684):e1\u2013e9","journal-title":"Am Heart J"},{"key":"747_CR13","doi-asserted-by":"crossref","unstructured":"Connolly SJ, Ezekowitz MD, Yusuf S, et al., and the RE-LY Steering Committee and Investigators(2009) Dabigatran versus Warfarin in Patients with Atrial Fibrillation. N Engl J Med361:1139-1151","DOI":"10.1056\/NEJMoa0905561"},{"key":"747_CR14","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJMra044440","volume":"353","author":"M Nisio Di","year":"2005","unstructured":"Di Nisio M, Middeldorp S, B\u00fcller HR (2005) Direct thrombin inhibitors. N Engl J Med 353:1028\u20131040","journal-title":"N Engl J Med"},{"key":"747_CR15","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1056\/NEJM198605153142006","volume":"314","author":"LH Clouse","year":"1986","unstructured":"Clouse LH, Comp PC (1986) The regulation of hemostasis: The protein C system. N Engl J Med 314:1298","journal-title":"N Engl J Med"},{"key":"747_CR16","doi-asserted-by":"crossref","first-page":"789","DOI":"10.7326\/0003-4819-100-6-789","volume":"100","author":"DJ Weinreich","year":"1984","unstructured":"Weinreich DJ, Burke JF, Pauletto FJ (1984) Left ventricular mural thrombi complicating acute myocardial infarction. Long-term follow-up with serial echocardiography. Ann Intern Med 100:789\u2013794","journal-title":"Ann Intern Med"},{"key":"747_CR17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-1-4899-2418-6_3","volume":"340","author":"DW Banner","year":"1993","unstructured":"Banner DW, Hadvary P (1993) Inhibitor binding to thrombin: X-ray crystallographic studies. Adv Exp Med Biol 340:27\u201333","journal-title":"Adv Exp Med Biol"},{"key":"747_CR18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0049-3848(98)00192-3","volume":"93","author":"J Hauptmann","year":"1999","unstructured":"Hauptmann J, Sturzebecher J (1999) Synthetic inhibitors of thrombin and factor Xa: from bench to bedside. Thromb Res 93:203\u2013241","journal-title":"Thromb Res"},{"key":"747_CR19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/01.CIR.97.3.251","volume":"97","author":"Z Xiao","year":"1998","unstructured":"Xiao Z, Theroux P (1998) Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor. Circulation 97:251\u2013256","journal-title":"Circulation"},{"key":"747_CR20","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0735-1097(02)02868-1","volume":"41","author":"TC Sarich","year":"2003","unstructured":"Sarich TC, Wolzt M, Eriksson UG et al (2003) Effects of ximelagatran, an oral direct thrombin inhibitor, r-hirudin and enoxaparin on thrombin generation and platelet activation in healthy male subjects. J Am Coll Cardiol 41:557\u2013564","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-012-0747-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-012-0747-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-012-0747-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T07:01:55Z","timestamp":1559372515000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-012-0747-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,27]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["747"],"URL":"https:\/\/doi.org\/10.1007\/s11239-012-0747-1","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,27]]}}}